Potential Link of Microalbuminuria with Metabolic Syndrome in Patients Undergoing Coronary Angiography

Archives of Medical Research

Volumn 40, Issue 5, 2009, Pages 399-405

  Anvari, Maryam Sotoudeh ^a   Boroumand, Mohammad Ali ^a   Pourgholi, Leila ^a   Sheikhfathollahi, Mahmood ^a   Rouhzendeh, Mahmoud ^a   Rabbani, Shahram ^a   Goodarzynejad, Hamidreza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cardiovascular risk; Coronary artery disease; Metabolic syndrome; Microalbuminuria

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MICROALBUMINURIA; PREVALENCE; RISK ASSESSMENT; RISK FACTOR;

AGED; ALBUMINURIA; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FEMALE; GLUCOSE; HUMANS; IRAN; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; RISK FACTORS;

EID: 70349103733     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2009.06.011     Document Type: Article

References (46)

1. Balkau B., Charles M.A., Drivsholm T., et al. Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diabetes Metab 28 (2002) 364-376
2. Hanson R.L., Imperatore G., Bennett P.H., et al. Components of the "metabolic syndrome" and incidence of type 2 diabetes. Diabetes 51 (2002) 3120-3127
3. Klein B.E., Klein R., and Lee K.E. Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in Beaver Dam. Diabetes Care 25 (2002) 1790-1794
4. Grundy S.M., Brewer Jr. H.B., Cleeman J.I., et al. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Arterioscler Thromb Vasc Biol 24 (2004) e13-e18
5. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO Consultation (1999)
6. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
7. Grundy S.M., Cleeman J.I., Daniels S.R., et al. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive summary. Cardiol Rev 13 (2005) 322-327
8. Alberti K.G., Zimmet P., and Shaw J. Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 23 (2006) 469-480
9. Saely C.H., Koch L., Schmid F., et al. Adult Treatment Panel III 2001 but not International Diabetes Federation 2005 criteria of the metabolic syndrome predict clinical cardiovascular events in subjects who underwent coronary angiography. Diabetes Care 29 (2006) 901-907
10. Klausen K.P., Parving H.H., Scharling H., et al. The association between metabolic syndrome, microalbuminuria and impaired renal function in the general population: impact on cardiovascular disease and mortality. J Intern Med 262 (2007) 470-478
11. Freedman B.I., Langefeld C.D., Lohman K.K., et al. Relationship between albuminuria and cardiovascular disease in Type 2 diabetes. J Am Soc Nephrol 16 (2005) 2156-2161
12. Yuyun M.F., Khaw K.T., Luben R., et al. Microalbuminuria independently predicts all-cause and cardiovascular mortality in a British population: The European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) population study. Int J Epidemiol 33 (2004) 189-198
13. Kramer H., Jacobs Jr. D.R., Bild D., et al. Urine albumin excretion and subclinical cardiovascular disease. The Multi-Ethnic Study of Atherosclerosis. Hypertension 46 (2005) 38-43
14. Klausen K.P., Scharling H., Jensen G., et al. New definition of microalbuminuria in hypertensive subjects: association with incident coronary heart disease and death. Hypertension 46 (2005) 33-37
15. Dinneen S.F., and Gerstein H.C. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature. Arch Intern Med 157 (1997) 1413-1418
16. Chen J., Muntner P., Hamm L.L., et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 140 (2004) 167-174
17. Jones C.A., Francis M.E., Eberhardt M.S., et al. Microalbuminuria in the US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis 39 (2002) 445-459
18. Palaniappan L., Carnethon M., and Fortmann S.P. Association between microalbuminuria and the metabolic syndrome: NHANES III. Am J Hypertens 16 (2003) 952-958
19. Brantsma A.H., Bakker S.J., Hillege H.L., et al. Urinary albumin excretion and its relation with C-reactive protein and the metabolic syndrome in the prediction of type 2 diabetes. Diabetes Care 28 (2005) 2525-2530
20. Rowley K., O'Dea K., and Best J.D. Association of albuminuria and the metabolic syndrome. Curr Diab Rep 3 (2003) 80-86
21. Mykkanen L., Zaccaro D.J., Wagenknecht L.E., et al. Microalbuminuria is associated with insulin resistance in nondiabetic subjects: the insulin resistance atherosclerosis study. Diabetes 47 (1998) 793-800
22. Bianchi C., Penno G., Daniele G., et al. The metabolic syndrome is related to albuminuria in Type 2 diabetes. Diabet Med 25 (2008) 1412-1418
23. Franciosi M., Pellegrini F., Sacco M., et al. Identifying patients at risk for microalbuminuria via interaction of the components of the metabolic syndrome: a cross-sectional analytic study. Clin J Am Soc Nephrol 2 (2007) 984-991
24. Luk A.O., Ma R.C., So W.Y., et al. The NCEP-ATPIII but not the IDF criteria for the metabolic syndrome identify Type 2 diabetic patients at increased risk of chronic kidney disease. Diabet Med 25 (2008) 1419-1425
25. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
26. Gensini G.G. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 51 (1983) 606
27. Boroumand M.A., Rekabi V., Davoodi G., et al. Correlation between lipoprotein (a) serum concentration and severity of coronary artery stenosis in an Iranian population according to Gensini score. Clin Biochem 41 (2008) 117-120
28. Boroumand M., Ghaedi M., Mohammadtaghvaei N., et al. Association of estrogen receptor alpha gene polymorphism with the presence of coronary artery disease documented by coronary angiography. Clin Biochem 42 (2009) 835-839
29. Jassal S.K., Langenberg C., von Muhlen D., et al. Usefulness of microalbuminuria versus the metabolic syndrome as a predictor of cardiovascular disease in women and men >40 years of age (from the Rancho Bernardo Study). Am J Cardiol 101 (2008) 1275-1280
30. de Jong P.E., Hillege H.L., Pinto-Sietsma S.J., et al. Screening for microalbuminuria in the general population: a tool to detect subjects at risk for progressive renal failure in an early phase?. Nephrol Dial Transplant 18 (2003) 10-13
31. Isomaa B., Almgren P., Tuomi T., et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24 (2001) 683-689
32. Behrendt D., and Ganz P. Endothelial function. From vascular biology to clinical applications. Am J Cardiol 90 (2002) 40L-48L
33. Maxwell A.J. Mechanisms of dysfunction of the nitric oxide pathway in vascular diseases. Nitric Oxide 6 (2002) 101-124
34. Stehouwer C.D., Lambert J., Donker A.J., et al. Endothelial dysfunction and pathogenesis of diabetic angiopathy. Cardiovasc Res 34 (1997) 55-68
35. Paniagua O.A., Bryant M.B., and Panza J.A. Role of endothelial nitric oxide in shear stress-induced vasodilation of human microvasculature: diminished activity in hypertensive and hypercholesterolemic patients. Circulation 103 (2001) 1752-1758
36. Zhang W.Z., Venardos K., Chin-Dusting J., et al. Adverse effects of cigarette smoke on NO bioavailability: role of arginine metabolism and oxidative stress. Hypertension 48 (2006) 278-285
37. Salmenniemi U., Ruotsalainen E., Pihlajamaki J., et al. Multiple abnormalities in glucose and energy metabolism and coordinated changes in levels of adiponectin, cytokines, and adhesion molecules in subjects with metabolic syndrome. Circulation 110 (2004) 3842-3848
38. Tuttle K.R., Puhlman M.E., Cooney S.K., et al. Urinary albumin and insulin as predictors of coronary artery disease: an angiographic study. Am J Kidney Dis 34 (1999) 918-925
39. Asselbergs F.W., de Boer R.A., Diercks G.F., et al. Vascular endothelial growth factor: the link between cardiovascular risk factors and microalbuminuria?. Int J Cardiol 93 (2004) 211-215
40. Yu Y., Suo L., Yu H., et al. Insulin resistance and endothelial dysfunction in type 2 diabetes patients with or without microalbuminuria. Diabetes Res Clin Pract 65 (2004) 95-104
41. Pascual J.M., Rodilla E., Gonzalez C., Perez-Hoyos S., and Redon J. Long-term impact of systolic blood pressure and glycemia on the development of microalbuminuria in essential hypertension. Hypertension 45 (2005) 1125-1130
42. Wang T.J., Evans J.C., Meigs J.B., et al. Low-grade albuminuria and the risks of hypertension and blood pressure progression. Circulation 111 (2005) 1370-1376
43. Imanishi M., Yoshioka K., Konishi Y., et al. Glomerular hypertension as one cause of albuminuria in type II diabetic patients. Diabetologia 42 (1999) 999-1005
44. Lin C.C., Liu C.S., Li T.C., et al. Microalbuminuria and the metabolic syndrome and its components in the Chinese population. Eur J Clin Invest 37 (2007) 783-790
45. Konta T., Hao Z., Abiko H., et al. Prevalence and risk factor analysis of microalbuminuria in Japanese general population: the Takahata study. Kidney Int 70 (2006) 751-756
46. Chaiken R.L., Khawaja R., Bard M., et al. Utility of untimed urinary albumin measurements in assessing albuminuria in black NIDDM subjects. Diabetes Care 20 (1997) 709-713